Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNFT
1651
DELISTED
Benefitfocus, Inc.
BNFT
| $5.45M | 0.01% |
149,800
-28,900
| -16% | -$927K |
|
|
BSQR
1652
DELISTED
BSQUARE Corporation
BSQR
| $5.43M | 0.01% |
969,775
+17,000
| +2% | +$86.7K |
|
|
SAVE
1653
DELISTED
Spirit Airlines, Inc.
SAVE
| $5.43M | 0.01% |
+105,100
| New | +$5.75M |
|
1654
Columbus McKinnon
CMCO
$556M
| $5.43M | 0.01% |
213,485
+157,885
| +284% | +$4.09M |
|
|
SHYF
1655
DELISTED
The Shyft Group
SHYF
| $5.42M | 0.01% |
612,800
+58,100
| +10% | +$491K |
|
|
OLBK
1656
DELISTED
Old Line Bancshares, Inc.
OLBK
| $5.42M | 0.01% |
192,200
+16,500
| +9% | +$460K |
|
|
EGL
1657
DELISTED
Engility Holdings, Inc.
EGL
| $5.41M | 0.01% |
190,600
-18,400
| -9% | -$513K |
|
1658
Travelzoo
TZOO
$73.4M
| $5.41M | 0.01% |
494,100
+37,900
| +8% | +$378K |
|
1659
Gentex
GNTX
$5.03B
| $5.4M | 0.01% |
+284,796
| New | +$5.55M |
|
|
MOFG
1660
DELISTED
MidWestOne Financial Group
MOFG
| $5.39M | 0.01% |
159,000
+29,300
| +23% | +$1.02M |
|
|
KE
1661
Kimball Electronics
KE
$622M
| $5.37M | 0.01% |
297,475
-53,100
| -15% | -$915K |
|
|
DWCH
1662
DELISTED
Datawatch Corp
DWCH
| $5.36M | 0.01% |
576,800
+352,200
| +157% | +$2.89M |
|
1663
MYR Group
MYRG
$5.21B
| $5.35M | 0.01% |
172,400
-41,000
| -19% | -$1.41M |
|
1664
First Community Bankshares
FCBC
$936M
| $5.35M | 0.01% |
195,500
-8,892
| -4% | -$232K |
|
1665
Ameriprise Financial
AMP
$50.3B
| $5.35M | 0.01% |
+42,000
| New | +$5.33M |
|
|
ESGR
1666
DELISTED
Enstar Group
ESGR
| $5.34M | 0.01% |
26,900
-21,700
| -45% | -$4.15M |
|
|
CNCE
1667
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $5.32M | 0.01% |
381,100
+16,300
| +4% | +$240K |
|
1668
Knowles
KN
$3.29B
| $5.31M | 0.01% |
314,074
+129,700
| +70% | +$2.33M |
|
1669
PC Connection
CNXN
$2.05B
| $5.31M | 0.01% |
196,300
+15,900
| +9% | +$438K |
|
1670
Richardson Electronics
RELL
$299M
| $5.31M | 0.01% |
889,799
-14,700
| -2% | -$87.6K |
|
|
USCR
1671
DELISTED
U S Concrete, Inc.
USCR
| $5.31M | 0.01% |
+67,615
| New | +$4.6M |
|
1672
Insight Enterprises
NSIT
$4.53B
| $5.31M | 0.01% |
132,778
+85,805
| +183% | +$3.62M |
|
|
PCMI
1673
DELISTED
PCM, Inc
PCMI
| $5.3M | 0.01% |
282,900
-204,700
| -42% | -$4.48M |
|
1674
FTAI Aviation
FTAI
$22.3B
| $5.3M | 0.01% |
389,478
+172,078
| +79% | +$2.3M |
|
|
EIGI
1675
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $5.3M | 0.01% |
634,400
+447,000
| +239% | +$3.47M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.